Document is current
Any future updates will be listed below
-
Authors
Nestler, Sophie
Apfelbacher, Christian
Özkan, Ebru
Naber, Kurt
Piontek, Katharina
-
Funding
Funding for this research was provided by:
Otto-von-Guericke-Universität Magdeburg
- License Information
-
More Information
Article History
Received: 23 August 2024
Accepted: 30 November 2024
First Online: 25 January 2025
Declarations
:
: The study was approved by the Ethics Committee of the Otto-von-Guericke University, Medical Faculty and University Hospital Magdeburg (No. 73/23). All study participants gave written informed consent.
: Not applicable.
: CA received institutional funding from Bionorica SE and Dr Wolf Group and consultancy fees from Bionorica SE, Dr Wolff Group, Rheacell, Sanofi, Pfizer, LEOPharma and Incyte for services related to patient-reported outcome measures. KN is one of the copyright holders of the ACSS, and received consultancy fees from Bionorica, BioMerieux, GlaxoSmithKline, Immunotek, Ingenion Medical, Johnson & Johnson, MIP Pharma, and OM Pharma. All other authors declare that they have no conflict of interest.
